Rustgi, Vinod K.

Publishing since 1987 (Dinosaur)

Has published 33 publications in 23 years

Number of publications published per year by Rustgi, Vinod K.. (Source : PubMed)

Distribution of publications types for Rustgi, Vinod K.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Rustgi VK, Lee WM, Lawitz E, Gordon SC, Afdhal N, Poordad F, Bonkovsky HL, Bengtsson L, Chandorkar G, Harding M, McNair L, Aalyson M, Alam J, Kauffman R, Gharakhanian S, McHutchison JG. Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.  Hepatology  2009;50;6  
•  Rustgi VK. Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C.  Curr Med Res Opin  2009;25;4  
•  Rustgi VK, Davis GL, Herrine SK, McCullough AJ, Friedman SL, Gores GJ. Future trends in hepatology: challenges and opportunities.  Hepatology  2008;48;2  
•  Kotlyar DS, Blonski W, Rustgi VK. Noninvasive monitoring of hepatitis C fibrosis progression.  Clin Liver Dis  2008;12;3  
•  Sherman M, Yurdaydin C, Simsek H, Silva M, Liaw YF, Rustgi VK, Sette H, Tsai N, Tenney DJ, Vaughan J, Kreter B, Hindes R. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.  Hepatology  2008;48;1  
•  Rustgi VK, Esposito S, Hamzeh FM, Shiffman ML. Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.  Aliment. Pharmacol. Ther.  2008;27;5  
•  Di Bisceglie AM, Ghalib RH, Hamzeh FM, Rustgi VK. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.  J. Viral Hepat.  2007;14;10  
•  Rustgi VK. Thymalfasin for the treatment of chronic hepatitis C infection.  Ann. N. Y. Acad. Sci.  2007;1112  
•  Rustgi VK. The epidemiology of hepatitis C infection in the United States.  J. Gastroenterol.  2007;42;7  
•  Shiffman ML, Rustgi VK. Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.  Gastroenterology  2006;131;4  

[ See timeline ] [ See all publications ]